Summary of marrow-derived cell plasticity studies
Tissue of origin . | Tissue formed . | In vivo . | In vitro . | Donor marker . | Function . | Reference . |
---|---|---|---|---|---|---|
BM | Muscle | + | − | β-galactosidase | − | 43 |
— | + | − | Genomic sequence, dystrophin | − | 45 | |
— | + | − | Dystrophin, Y chromosome | − | 44 | |
— | + | − | GFP | − | 46 | |
BM | Brain (neurons and macroglia) | + | − | Retroviral marking, Y chromosome | − | 2 |
— | + | − | GFP | − | 3,47 | |
— | + | − | Y chromosome | − | 48 | |
— | + | − | Human specific in xenogeneic background | − | 23 | |
— | + | − | Y chromosome | − | H4 | |
— | + | − | β-galactosidase | ± | R52 | |
— | − | + | NA | − | H5 | |
BM | Liver | + | − | Y chromosome | − | R26 |
— | + | − | β-galactosidase, FAH | + | 32 | |
— | + | − | Y chromosome | − | 27 | |
— | + | − | Y chromosome | − | H29,33 | |
— | + | − | Human specific in xenogeneic background | − | HX6,7 | |
— | + | − | Y chromosome, C3 antigen | ± | R8 | |
— | − | + | NA | − | R9 | |
— | − | + | NA | − | H10 | |
— | + | + | Human specific in xenogeneic background | − | HX11 | |
BM | Cardiac myocytes | + | − | GFP | ± | 38 |
— | + | − | β-galactosidase | − | 12 | |
Circulating cells | Cardiac myocytes | + | − | Y chromosome | − | H40 |
BM KTLS | Purkinje neuron | + | − | GFP | − | 83 |
BM KTLS | Liver | + | − | GFP | − | 83 |
— | + | − | β-galactosidase, FAH | + | 32 | |
BM | Kidney | + | − | Y chromosome | − | H55 |
— | + | − | β-galactosidase | + | 59 | |
— | + | − | β-galactosidase, Y | − | 13 | |
BM | GI | + | − | Y chromosome | − | H33,68 |
— | + | − | Y chromosome | − | 14 | |
BM | Lung | + | − | Y chromosome | − | 15 |
BM | Skin | + | − | Y chromosome | − | H33,66 |
— | + | − | Y chromosome | − | 14 | |
— | + | − | GFP | − | 67 | |
MSC | Lung | + | − | β-galactosidase | − | 64 |
— | + | − | Y chromosome | + | 15 | |
MSC | Neuronal cells | − | + | NA | − | 16,17 |
— | + | − | BrdU | − | 18 | |
— | − | +* | NA | ± | H19 | |
— | + | − | GFP | − | HX20 | |
BM MAPC | Blood | + | − | β-galactosidase | − | 19 |
BM MAPC | Lung | + | − | β-galactosidase | − | 19 |
BM MAPC | Skin | + | − | β-galactosidase | − | 19 |
BM MAPC | GI | + | − | β-galactosidase | − | 19 |
BM MAPC | Liver | − | +† | NA | + | 21 |
— | + | − | β-galactosidase | − | 19 |
Tissue of origin . | Tissue formed . | In vivo . | In vitro . | Donor marker . | Function . | Reference . |
---|---|---|---|---|---|---|
BM | Muscle | + | − | β-galactosidase | − | 43 |
— | + | − | Genomic sequence, dystrophin | − | 45 | |
— | + | − | Dystrophin, Y chromosome | − | 44 | |
— | + | − | GFP | − | 46 | |
BM | Brain (neurons and macroglia) | + | − | Retroviral marking, Y chromosome | − | 2 |
— | + | − | GFP | − | 3,47 | |
— | + | − | Y chromosome | − | 48 | |
— | + | − | Human specific in xenogeneic background | − | 23 | |
— | + | − | Y chromosome | − | H4 | |
— | + | − | β-galactosidase | ± | R52 | |
— | − | + | NA | − | H5 | |
BM | Liver | + | − | Y chromosome | − | R26 |
— | + | − | β-galactosidase, FAH | + | 32 | |
— | + | − | Y chromosome | − | 27 | |
— | + | − | Y chromosome | − | H29,33 | |
— | + | − | Human specific in xenogeneic background | − | HX6,7 | |
— | + | − | Y chromosome, C3 antigen | ± | R8 | |
— | − | + | NA | − | R9 | |
— | − | + | NA | − | H10 | |
— | + | + | Human specific in xenogeneic background | − | HX11 | |
BM | Cardiac myocytes | + | − | GFP | ± | 38 |
— | + | − | β-galactosidase | − | 12 | |
Circulating cells | Cardiac myocytes | + | − | Y chromosome | − | H40 |
BM KTLS | Purkinje neuron | + | − | GFP | − | 83 |
BM KTLS | Liver | + | − | GFP | − | 83 |
— | + | − | β-galactosidase, FAH | + | 32 | |
BM | Kidney | + | − | Y chromosome | − | H55 |
— | + | − | β-galactosidase | + | 59 | |
— | + | − | β-galactosidase, Y | − | 13 | |
BM | GI | + | − | Y chromosome | − | H33,68 |
— | + | − | Y chromosome | − | 14 | |
BM | Lung | + | − | Y chromosome | − | 15 |
BM | Skin | + | − | Y chromosome | − | H33,66 |
— | + | − | Y chromosome | − | 14 | |
— | + | − | GFP | − | 67 | |
MSC | Lung | + | − | β-galactosidase | − | 64 |
— | + | − | Y chromosome | + | 15 | |
MSC | Neuronal cells | − | + | NA | − | 16,17 |
— | + | − | BrdU | − | 18 | |
— | − | +* | NA | ± | H19 | |
— | + | − | GFP | − | HX20 | |
BM MAPC | Blood | + | − | β-galactosidase | − | 19 |
BM MAPC | Lung | + | − | β-galactosidase | − | 19 |
BM MAPC | Skin | + | − | β-galactosidase | − | 19 |
BM MAPC | GI | + | − | β-galactosidase | − | 19 |
BM MAPC | Liver | − | +† | NA | + | 21 |
— | + | − | β-galactosidase | − | 19 |
All data are from mouse unless otherwise indicated. Not included in this table are reports of BM-derived cells differentiating into cells of the endothelium, mesangium, bone, fat, or cartilage. For in vitro assays, cell-type-specific markers were assessed using either RT-PCR or antibody staining. It is unknown whether the cells produced in vitro are functional. Note that no mechanism is implied by this listing. Findings may be attributed to direct differentiation of BM-derived cells, indirect differentiation, fusion, or a combination of these mechanisms.
BM indicates bone marrow; BrdU, 5-bromodeoxyuridine; R, rat; H, human; X, xenogeneic transplantation of human cells into mice or rats; KTLS, Lin−kit+Sca+Thy1lo; NA, not applicable; and Function, study showed that the cells are functional.
In vitro electrophysiological studies were performed.
In vitro urea metabolism was assessed.